Atlas Trials

Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma

Clinical trial NCT01411579 · COMPLETED

Trial details

NCT number
NCT01411579
Sponsor
Stefano Colagrande
Status
COMPLETED
Study type
OBSERVATIONAL
Liver MetastasesHepatocarcinoma
Start date
2011-02-01
Primary completion
2012-02-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.